A global leader and champion of women’s health for more than three decades, Hologic produces innovative, science-backed products that help healthcare professionals around the world treat their patients with precision, certainty and confidence. Hologic is a world leader in the early detection of breast and cervical cancer, in testing for infectious diseases including COVID-19 and HIV, and in women’s surgical products. In pursuit of its “Purpose, Passion and Promise,” Hologic partners with organizations such as the President’s Emergency Action Plan for AIDS Relief (PEPFAR) and the Black Women’s Health Imperative to ensure that communities worldwide have access to best-in-class testing, screening and early detection. 

Amid the uncertainty of the COVID-19 pandemic, Hologic partnered with Gallup, Inc. to create the first global measure to track the progress of women’s health: the Hologic Global Women’s Health Index. Based on individual responses from more than 120,000 people across 116 countries and territories, the Index examines critical markers for women’s health, by country and territory, and over time. The Index not only highlights key issues, it provides an actionable data roadmap for improving women’s life expectancy and quality of life.